지질 영양 시장 : 시장 규모, 점유율, 성장, 업계 분석, 지역별 동향 및 예측(2026-2034년)

Growth Factors of lipid nutrition Market

The global lipid nutrition market is experiencing steady growth due to increasing consumer awareness regarding preventive healthcare, functional nutrition, and the health benefits associated with essential fatty acids. According to the report, the global lipid nutrition market size was valued at USD 15.17 billion in 2025. The market is projected to grow from USD 16.11 billion in 2026 to USD 27.02 billion by 2034, exhibiting a CAGR of 6.67% during the forecast period. In 2025, North America dominated the market with a share of 35.13%, supported by strong demand for omega-3 supplements, functional foods, and dietary nutrition products.

Lipid nutrition refers to the intake and utilization of fats and fat-based compounds such as omega-3, omega-6 fatty acids, phospholipids, medium-chain triglycerides (MCTs), and structured lipids. These nutrients play a vital role in energy production, cardiovascular health, cognitive development, immune support, and cellular function.

Market Definition and Scope

Lipid nutrition products are widely used across dietary supplements, infant nutrition, functional foods and beverages, sports nutrition, and clinical nutrition applications. These products are designed to improve overall health and wellness by providing essential fatty acids and bioactive lipid compounds.

The market scope includes omega-3, omega-6, structured lipids, specialty phospholipids, MCTs, and other specialty lipids available in liquid and dry forms. Growing demand for personalized nutrition, healthy aging solutions, and preventive healthcare is expanding the adoption of lipid-based nutritional products globally.

Market Dynamics

Drivers

The increasing prevalence of lifestyle-related diseases, including cardiovascular disorders, obesity, and cognitive health issues, is a major driver of market growth. Rising awareness regarding the health benefits of omega-3 and omega-6 fatty acids has significantly increased demand for dietary supplements and functional nutrition products.

In addition, growing utilization of lipid nutrition ingredients in infant formula, sports nutrition, and clinical nutrition products is supporting market expansion worldwide.

Trends

A key trend shaping the market is the growing preference for sustainable and plant-based lipid sources. Consumers are increasingly seeking environmentally friendly alternatives derived from algae, seeds, and other plant-based ingredients.

Technological advancements such as microencapsulation are improving product stability, taste masking, and bioavailability. Furthermore, the growing popularity of personalized nutrition and clean-label products is encouraging manufacturers to develop customized lipid formulations for targeted health benefits.

Restraints

High production costs associated with marine-based lipids, including fish oil and algal oil, remain a significant challenge. Raw material supply fluctuations, environmental concerns, and overfishing issues can impact availability and pricing.

Additionally, oxidation and stability concerns may affect product shelf life and efficacy. Regulatory complexities regarding health claims and ingredient approvals across different countries also limit market growth.

Opportunities

The increasing demand for plant-based nutrition products presents substantial growth opportunities for market participants. Algae-derived omega-3 ingredients and seed-based lipid solutions are gaining popularity among vegan and environmentally conscious consumers.

Innovations in delivery technologies and advanced encapsulation systems are also creating new opportunities by improving product performance and expanding application possibilities across functional foods and beverages.

Segmentation Analysis

By Product Type

The omega-3 segment dominated the global market in 2025. Strong scientific evidence supporting cardiovascular health, brain development, vision support, and anti-inflammatory benefits has made omega-3 the most widely consumed lipid nutrition ingredient globally.

The structured lipids segment is anticipated to grow at a CAGR of 5.97% during the forecast period due to increasing demand for targeted nutritional solutions and specialized medical nutrition products.

By Form

The liquid segment accounted for the largest market share in 2025. Liquid lipid nutrition products offer superior bioavailability, easier absorption, and broad applicability across supplements, infant formula, and functional beverages.

The dry segment is projected to grow at a CAGR of 6.62% through 2034 owing to its longer shelf life, ease of transportation, and suitability for capsules, powders, and fortified food products.

By Application

The dietary supplements segment led the market in 2025 due to rising consumer focus on preventive healthcare and wellness management. Strong retail availability and expanding e-commerce distribution channels continue to support segment growth.

The clinical nutrition segment is expected to grow at a CAGR of 6.36% during the forecast period, driven by increasing use of lipid-based formulations in hospitals and specialized healthcare settings.

Regional Insights

North America dominated the global lipid nutrition market and reached a valuation of USD 5.33 billion in 2025. High consumer awareness, a mature dietary supplement industry, and growing demand for preventive healthcare products continue to drive regional growth. The U.S. market alone accounted for USD 4.45 billion in 2025.

Asia Pacific was valued at USD 4.57 billion in 2025 and represents the fastest-growing regional market. Rising disposable incomes, expanding middle-class populations, and increasing demand for infant nutrition and dietary supplements are supporting growth across China, India, and Japan.

Europe reached USD 3.22 billion in 2025, driven by strong demand for functional foods, sustainable ingredients, and premium nutrition products. Germany and the U.K. remain key contributors to regional market expansion.

South America and the Middle East & Africa are witnessing steady growth due to improving healthcare infrastructure, increasing health awareness, and rising demand for nutritional supplements.

Competitive Landscape

The lipid nutrition market is moderately consolidated, with major companies focusing on product innovation, acquisitions, and strategic partnerships. Leading players include Croda International Plc, Cargill Incorporated, Kerry Group, Archer Daniels Midland (ADM), Aker BioMarine, KD Pharma Group, Evonik Industries AG, FrieslandCampina Ingredients, and Louis Dreyfus Company (LDC).

Companies continue to invest heavily in research and development to expand their portfolios in omega-3, infant nutrition, clinical nutrition, and plant-based lipid ingredients.

Report Coverage

The report provides a comprehensive analysis of the global lipid nutrition market, including market size estimates for 2025, 2026, and 2034. It covers market drivers, restraints, trends, opportunities, segmentation analysis, regional outlook, competitive landscape, and major industry developments influencing future market growth.

Conclusion

The global lipid nutrition market is projected to grow from USD 16.11 billion in 2026 to USD 27.02 billion by 2034, driven by rising awareness of preventive healthcare, growing demand for functional nutrition, and increasing adoption of omega-3 and specialty lipid products. Continued innovation in plant-based ingredients, personalized nutrition, and advanced delivery technologies is expected to create new growth opportunities, supporting the market's long-term expansion worldwide.

Segmentation By Product Type, By Form, By Application, and Region

By Product Type * Omega-3

• Structured Lipids
• MCTs
• Specialty Phospholipids
• Omega-6
• Other Specialty Lipids

By Form * Dry

• Liquid

By Application * Dietary Supplements

• Functional Food & Beverage
• Clinical Nutrition

By Region * North America (By Product Type, By Form, By Application, and Country)

• U.S. (By Form)
• Canada (By Form)
• Mexico (By Form)
• Europe (By Product Type, By Form, By Application, and Country)
  • Germany (By Form)
  • France (By Form)
  • Italy (By Form)
  • U.K. (By Form)
  • Spain (By Form)
  • Rest of Europe (By Form)
• Asia Pacific (By Product Type, By Form, By Application, and Country)
  • China (By Form)
  • India (By Form)
  • Japan (By Form)
  • Australia (By Form)
  • Rest of Asia Pacific (By Form)
• South America (By Product Type, By Form, By Application, and Country)
  • Brazil (By Form)
  • Argentina (By Form)
  • Rest of South America (By Form)
• Middle East and Africa (By Product Type, By Form, By Application, and Country)
  • South Africa (By Form)
  • UAE (By Form)
  • Rest of the Middle East & Africa (By Form)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Market Overview of Related/Parent Market
• 4.2. Supply Chain Analysis
• 4.3. Regulatory Analysis
• 4.4. Industry SWOT Analysis
• 4.5. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches
• 4.6. Tariff Impact on the Market

5. Global Lipid Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 5.1. Key Findings / Summary
• 5.2. Market Size Estimates and Forecast
  • 5.2.1. By Product Type (Value)
    • 5.2.1.1. Omega-3
    • 5.2.1.2. Structured Lipids
    • 5.2.1.3. MCTs
    • 5.2.1.4. Specialty Phospholipids
    • 5.2.1.5. Omega-6
    • 5.2.1.6. Other Specialty Lipids
  • 5.2.2. By Form (Value)
    • 5.2.2.1. Dry
    • 5.2.2.2. Liquid
  • 5.2.3. By Application (Value)
    • 5.2.3.1. Dietary Supplements
    • 5.2.3.2. Functional Food & Beverage
    • 5.2.3.3. Clinical Nutrition
  • 5.2.4. By Region (Value)
    • 5.2.4.1. North America
    • 5.2.4.2. Europe
    • 5.2.4.3. Asia Pacific
    • 5.2.4.4. South America
    • 5.2.4.5. Middle East & Africa

6. North America Lipid Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Product Type (Value)
    • 6.2.1.1. Omega-3
    • 6.2.1.2. Structured Lipids
    • 6.2.1.3. MCTs
    • 6.2.1.4. Specialty Phospholipids
    • 6.2.1.5. Omega-6
    • 6.2.1.6. Other Specialty Lipids
  • 6.2.2. By Form (Value)
    • 6.2.2.1. Dry
    • 6.2.2.2. Liquid
  • 6.2.3. By Application (Value)
    • 6.2.3.1. Dietary Supplements
    • 6.2.3.2. Functional Food & Beverage
    • 6.2.3.3. Clinical Nutrition
  • 6.2.4. By Country
    • 6.2.4.1. U.S.
      • 6.2.4.1.1. By Form (Value)
        • 6.2.4.1.1.1. Dry
        • 6.2.4.1.1.2. Liquid
    • 6.2.4.2. Canada
      • 6.2.4.2.1. By Form (Value)
        • 6.2.4.2.1.1. Dry
        • 6.2.4.2.1.2. Liquid
    • 6.2.4.3. Mexico
      • 6.2.4.3.1. By Form (Value)
        • 6.2.4.3.1.1. Dry
        • 6.2.4.3.1.2. Liquid

7. Europe Lipid Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Product Type (Value)
    • 7.2.1.1. Omega-3
    • 7.2.1.2. Structured Lipids
    • 7.2.1.3. MCTs
    • 7.2.1.4. Specialty Phospholipids
    • 7.2.1.5. Omega-6
    • 7.2.1.6. Other Specialty Lipids
  • 7.2.2. By Form (Value)
    • 7.2.2.1. Dry
    • 7.2.2.2. Liquid
  • 7.2.3. By Application (Value)
    • 7.2.3.1. Dietary Supplements
    • 7.2.3.2. Functional Food & Beverage
    • 7.2.3.3. Clinical Nutrition
  • 7.2.4. By Country
    • 7.2.4.1. Germany
      • 7.2.4.1.1. By Form (Value)
        • 7.2.4.1.1.1. Dry
        • 7.2.4.1.1.2. Liquid
    • 7.2.4.2. U.K.
      • 7.2.4.2.1. By Form (Value)
        • 7.2.4.2.1.1. Dry
        • 7.2.4.2.1.2. Liquid
    • 7.2.4.3. France
      • 7.2.4.3.1. By Form (Value)
        • 7.2.4.3.1.1. Dry
        • 7.2.4.3.1.2. Liquid
    • 7.2.4.4. Italy
      • 7.2.4.4.1. By Form (Value)
        • 7.2.4.4.1.1. Dry
        • 7.2.4.4.1.2. Liquid
    • 7.2.4.5. Spain
      • 7.2.4.5.1. By Form (Value)
        • 7.2.4.5.1.1. Dry
        • 7.2.4.5.1.2. Liquid
    • 7.2.4.6. Rest of Europe
      • 7.2.4.6.1. By Form (Value)
        • 7.2.4.6.1.1. Dry
        • 7.2.4.6.1.2. Liquid

8. Asia Pacific Lipid Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 8.1. Key Findings / Summary
  • 8.1.1. By Product Type (Value)
    • 8.1.1.1. Omega-3
    • 8.1.1.2. Structured Lipids
    • 8.1.1.3. MCTs
    • 8.1.1.4. Specialty Phospholipids
    • 8.1.1.5. Omega-6
    • 8.1.1.6. Other Specialty Lipids
  • 8.1.2. By Form (Value)
    • 8.1.2.1. Dry
    • 8.1.2.2. Liquid
  • 8.1.3. By Application (Value)
    • 8.1.3.1. Dietary Supplements
    • 8.1.3.2. Functional Food & Beverage
    • 8.1.3.3. Clinical Nutrition
  • 8.1.4. By Country
    • 8.1.4.1. China
      • 8.1.4.1.1. By Form (Value)
        • 8.1.4.1.1.1. Dry
        • 8.1.4.1.1.2. Liquid
    • 8.1.4.2. India
      • 8.1.4.2.1. By Form (Value)
        • 8.1.4.2.1.1. Dry
        • 8.1.4.2.1.2. Liquid
    • 8.1.4.3. Japan
      • 8.1.4.3.1. By Form (Value)
        • 8.1.4.3.1.1. Dry
        • 8.1.4.3.1.2. Liquid
    • 8.1.4.4. Australia
      • 8.1.4.4.1. By Form (Value)
        • 8.1.4.4.1.1. Dry
        • 8.1.4.4.1.2. Liquid
    • 8.1.4.5. Rest of Asia Pacific
      • 8.1.4.5.1. By Form (Value)
        • 8.1.4.5.1.1. Dry
        • 8.1.4.5.1.2. Liquid

9. South America Lipid Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 9.1. Key Findings / Summary
  • 9.1.1. By Product Type (Value)
    • 9.1.1.1. Omega-3
    • 9.1.1.2. Structured Lipids
    • 9.1.1.3. MCTs
    • 9.1.1.4. Specialty Phospholipids
    • 9.1.1.5. Omega-6
    • 9.1.1.6. Other Specialty Lipids
  • 9.1.2. By Form (Value)
    • 9.1.2.1. Dry
    • 9.1.2.2. Liquid
  • 9.1.3. By Application (Value)
    • 9.1.3.1. Dietary Supplements
    • 9.1.3.2. Functional Food & Beverage
    • 9.1.3.3. Clinical Nutrition
  • 9.1.4. By Country
    • 9.1.4.1. Brazil
      • 9.1.4.1.1. By Form (Value)
        • 9.1.4.1.1.1. Dry
        • 9.1.4.1.1.2. Liquid
    • 9.1.4.2. Argentina
      • 9.1.4.2.1. By Form (Value)
        • 9.1.4.2.1.1. Dry
        • 9.1.4.2.1.2. Liquid
    • 9.1.4.3. Rest of South America
      • 9.1.4.3.1. By Form (Value)
        • 9.1.4.3.1.1. Dry
        • 9.1.4.3.1.2. Liquid

10. Middle East & Africa Lipid Nutrition Market Analysis, Insights and Forecast, 2026-2034

• 10.1. Key Findings / Summary
  • 10.1.1. By Product Type (Value)
    • 10.1.1.1. Omega-3
    • 10.1.1.2. Structured Lipids
    • 10.1.1.3. MCTs
    • 10.1.1.4. Specialty Phospholipids
    • 10.1.1.5. Omega-6
    • 10.1.1.6. Other Specialty Lipids
  • 10.1.2. By Form (Value)
    • 10.1.2.1. Dry
    • 10.1.2.2. Liquid
  • 10.1.3. By Application (Value)
    • 10.1.3.1. Dietary Supplements
    • 10.1.3.2. Functional Food & Beverage
    • 10.1.3.3. Clinical Nutrition
  • 10.1.4. By Country
    • 10.1.4.1. UAE
      • 10.1.4.1.1. By Form (Value)
        • 10.1.4.1.1.1. Dry
        • 10.1.4.1.1.2. Liquid
    • 10.1.4.2. South Africa
      • 10.1.4.2.1. By Form (Value)
        • 10.1.4.2.1.1. Dry
        • 10.1.4.2.1.2. Liquid
    • 10.1.4.3. Rest of the Middle East & Africa
      • 10.1.4.3.1. By Form (Value)
        • 10.1.4.3.1.1. Dry
        • 10.1.4.3.1.2. Liquid

11. Competitive Matrix

• 11.1. Business Strategies Adopted by Leading Players
• 11.2. Global Lipid Nutrition Market Revenue Share/Ranking Analysis, By Key Manufacturer, 2025

12. Company Profiles

• 12.1. Louis Dreyfus Company (LDC)
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Application Portfolio
  • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.1.5. Recent Developments
• 12.2. Croda International Plc
• 12.3. Cargill Incorporated
• 12.4. Archer Daniels Midland (ADM)
• 12.5. Aker BioMarine
• 12.6. KD Pharma Group
• 12.7. Evonik Industries AG
• 12.8. FrieslandCampina Ingredients
• 12.9. Polaris (Polaris Nutritional Lipids)
• 12.10. Kerry Group

13. Strategic Recommendations

14. Appendix